Data management

Science 37 taps NuvoAir to enable remote collection of lung health endpoints

20-Sep-2022 By Nick Taylor

Science 37 has partnered with NuvoAir to incorporate connected devices for the remote collection of respiratory endpoints data into clinical trial designs.

Bayer taps Clariness to build patient insights into clinical trial review process

13-Sep-2022 By Nick Taylor

Bayer Pharma has enlisted Clariness to support its new study review process by providing pre-clinical trial patient insights and post-trial feedback.

Use of RWE, AI elevating drug development: Sidley

12-Sep-2022 By Jenni Spinner

A fleet of legal professionals offers advice and perspective on important considerations when harnessing artificial intelligence and real-world evidence.

Real-world evidence helps accelerate research: Wolters Kluwer Health

12-Sep-2022 By Jenni Spinner

Experts from the health information specialist explain how the use of RWD and RWE has helped speed up and improve the development of therapies and vaccines.

DiMe releases digital health resources for atopic dermatitis endpoint

08-Sep-2022 By Jenni Spinner

The Digital Medicine Society is offering a library of resources to help promote the use of nocturnal scratch as an endpoint for the troubling skin condition.

Clarify, Datavant team up to securely connect first-party and real-world data

07-Sep-2022 By Nick Taylor

The companies will work together to help clients connect information sources, giving stakeholders a better overview of the clinical patient experience.

Sanofi strikes $20m AI drug discovery deal with Atomwise

07-Sep-2022 By Nick Taylor

The pharma company’s collaboration with the drug discovery specialist involves using artificial intelligence to discover and develop up to five drug targets.

CVS Health agrees to acquire Signify Health

06-Sep-2022 By Jenni Spinner

With the purchase, the company is looking to advance its plans to connect with potential trial participants and spread awareness of study participation.

DTRA glossary aims to promote adoption of decentralized format

06-Sep-2022 By Jenni Spinner

The Decentralized Trials and Research Alliance is offering the research resource to increase awareness, understanding, and acceptance of the study format.

Patient-centric approach benefits more than the patient: Quanticate

06-Sep-2022 By Jenni Spinner

A representative from the biometric contract research organization explains how taking a ‘patient comes first’ attitude can lead to a range of improvements.

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Syneos joins with physIQ, InCarda on atrial fibrillation study

30-Aug-2022 By Jenni Spinner

The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.

BMS forges multi-year research partnership with PathAI

25-Aug-2022 By Jenni Spinner

The pharmaceutical company and the artificial intelligence pathology specialist will focus on translational research in oncology, fibrosis, and immunology.

Include patient voice at every stage of clinical processes: Within3

23-Aug-2022 By Jenni Spinner

A leader suggests considering patient views and needs all along the clinical development path reaps a number of benefits, including time and cost savings.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

American Kidney Fund launches resources to engage patients of color

22-Aug-2022 By Jenni Spinner

The group has introduced a downloadable guide, interactive quiz, and other tools to inform patients from underrepresented communities about trial participation.

Is it time to start rethinking mobile clinical trial apps?

22-Aug-2022 By Jenni Spinner

A leader from the trial financial management specialist suggests apps used in trials could be adjusted to better suit patients, sites and other stakeholders.

Merck engages Saama Technologies to build ‘clinical data layer’

18-Aug-2022 By Jenni Spinner

The pharma firm will leverage the ClinTech leader's Life Science Analytics Cloud to bolster development capabilities and accelerate pipeline progress.

Predictive analytics could unlock precision medicine progress: AiCure

15-Aug-2022 By Jenni Spinner

An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.

Signant turns to Loftware for clinical supply chain management support

15-Aug-2022 By Nick Taylor

Signant Health has partnered with the software company o connect its platforms for the management of clinical supply chain inventory, labels, and content.

Merck partners with Cerevance on Alzheimer’s research initiative

11-Aug-2022 By Jenni Spinner

The pharmaceutical company has inked a strategic collaboration with the drug discovery firm, centering on uncovering novel targets in Alzheimer’s disease.

J&J, Evotec partner on ectodomain shedding drug discovery project

11-Aug-2022 By Jenni Spinner

Janssen has formed a strategic collaboration with the drug discovery specialist that involves applying TargetAlloMod platforms to protein homeostasis.

Improving patient adherence can elevate trial results: Sweetch

11-Aug-2022 By Jenni Spinner

A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.

MCI OneHealth, MDClone team up to use synthetic data to accelerate research

09-Aug-2022 By Nick Taylor

The two companies are collaborating to generate subject data sets designed to help users find insights that can speed up research and improve patient care.

People on the Move: August 2022

04-Aug-2022 By Jenni Spinner

This month’s announcements of appointments, partnerships, expansions, and mergers include Curia, Thread, TFF Pharmaceuticals, and other notable companies.

Medical specialty societies can benefit from regulatory progress: IQVIA

04-Aug-2022 By Jenni Spinner

An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.

Boehringer, Seqster ink 3-year health data deal to accelerate research

04-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

Blending human knowhow, artificial intelligence aids drug discovery

02-Aug-2022 By Jenni Spinner

A leader from pharmaceutical firm Astellas discusses how the company has put to use a discovery platform that combines human expertise, AI, and robotics.

Cancer Moonshot meeting brings together survivors, industry leaders

26-Jul-2022 By Jenni Spinner

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Biden’s call to improve screening and treatment options.

Human element important for decentralized trial advancement

25-Jul-2022 By Jenni Spinner

During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

Tech Innovations: July 2022

21-Jul-2022 By Jenni Spinner

This month’s announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

Yale, Vanderbilt, Morehouse join to increase trial diversity

21-Jul-2022 By Jenni Spinner

The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.

Collaboration sets sights on acceleration of cystic fibrosis research

20-Jul-2022 By Jenni Spinner

Epistemic AI, Cincinnati Children’s Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

Worldwide Clinical Trials, Invitae join to accelerate rare-disease studies

19-Jul-2022 By Jenni Spinner

The CRO and medical genetics company will collaborate to accelerate trials centered on rare diseases, using real-world data and genetic testing technology.

Patient voice, empathy key to pediatric study design: ICON

18-Jul-2022 By Jenni Spinner

A pediatric clinical trial expert from the CRO discusses the unique challenges involved in designing a study when the patients involved are little ones.

Online event centers on decentralized study solutions

18-Jul-2022 By Jenni Spinner

Taking place July 20, the Decentralized Trial Technology webinar will share insights and experiences from a group of knowledgeable virtual trial experts.

Recruitment tool pairs pharma firms with providers to boost patient connection

15-Jul-2022 By Jenni Spinner

Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.

False alarms thwart remote patient monitoring early warnings

15-Jul-2022 By Nick Taylor

A study out of Israel's Sheba Medical Center found wearables used to monitor patients can provide early warnings of deterioration, as well as false alarms.

Precision medicine advancements good news for drug development

12-Jul-2022 By Jenni Spinner

A leader from healthcare commercial intelligence company Definitive Healthcare discusses the rise of precision medicine and the benefits the field can yield.

Tech advances making decentralized trial growth possible: ICON

11-Jul-2022 By Jenni Spinner

In this second of a two-part series, a leader from the CRO discusses the types of technologies supporting DCTs and what might lie on the horizon for the field.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Merck accelerator welcomes biotech start-ups specializing in AI and machine learning

08-Jul-2022 By Rachel Arthur

Merck (MSD outside the US and Canada) is welcoming applications from early-stage biomedical start-ups for its newly launched Merck Digital Sciences Studio (MDSS): which seeks to support technologies for drug discovery and development.

Sema4, Avera Health partner on precision cancer care initiative

07-Jul-2022 By Jenni Spinner

The health care system and analytics company are joining on the ASAP study, a program that constitutes a five-year commitment to advancing cancer solutions.

Phesi analysis highlights extent of cancer trial inclusion issues

07-Jul-2022 By Jenni Spinner

The latest indepth report from the AI-centric analytics provider reveals nearly half of US cancer clinical studies enroll no Latino patient participants.

Decentralized clinical trial transformations are ‘here to stay’: ICON

06-Jul-2022 By Jenni Spinner

In this first of a two-part series, an expert discusses various factors behind the DCT format’s rapid rise and likely longevity in the drug development arena.

Decentralized trial technology center stage at online event

05-Jul-2022 By Jenni Spinner

On July 20, a collection of noted industry experts will lead a lively discussion on the rapid evolution of DCTs, and what advances might be on the horizon.

EHR app taps into remote patient monitoring technology

05-Jul-2022 By Jenni Spinner

Electronic health record solutions provider Athenahealth has partnered with Withings Health Solutions to put the RPM tech into place for clinical and care use.

AstraZeneca to buy blood cancer focused biotech in deal valued at up to $1.27bn

05-Jul-2022 By Jane Byrne

AstraZeneca is to acquire US-based blood cancer specialist, TeneoTwo, in a deal worth around US$1.27bn.

Note from the editor: Small but important changes ahead

30-Jun-2022 By Jenni Spinner

The past two years have been full of shifts and shakes in the drug development field, but the change at Outsourcing-Pharma is easy and one for the better.

Intelligent eCOA use enhances trials, amplifies patient voice: Medable

28-Jun-2022 By Jenni Spinner

An expert from the decentralized trial solutions company shares how eCOA and ePRO can be useful tools that improve the collection and quality of such data.